Literature DB >> 15269934

Does uncollected medication reduce the validity of pharmacy dispensing data?

Hilde Tobi1, Nico-Jan N van den Heuvel, Lolkje T W de Jong-van den Berg.   

Abstract

PURPOSE: When using pharmacy data as collected in the InterAction database (IADB) for pharmacoepidemiology studies, we tend to ignore the fact that filled prescriptions are not always collected by the patient. This study investigated whether unclaimed prescriptions pose a validity threat for pharmacy data, by estimating the percentage of filled prescriptions that are not collected, the percentage of patients who do not collect their filled prescriptions and describing the items remaining unclaimed.
METHODS: Prospective study in three independent pharmacies in the region that is covered by the IADB. All prescriptions that entered these pharmacies on 3 days in 1 week in October 2002 were monitored for a month with respect to whether and when they were claimed.
RESULTS: A total of 3946 prescriptions concerning 3082 patients were filled. The majority of prescriptions were collected the day they were filled. In total 18 prescription items (0.46%) were not collected within 1 month; excluding health products and homeopathic drugs 13 remained. These 13 covered a variety of drug groups; 0.45% of the patients did not claim their medication within 1 month.
CONCLUSIONS: Primary non-compliance due to not claiming medication has little impact on the validity of pharmacy dispensing data in the region under study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15269934     DOI: 10.1002/pds.928

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  6 in total

1.  The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands.

Authors:  Tjalling W de Vries; Hilde Tobi; Eric Schirm; Paul van den Berg; Eric J Duiverman; Lolkje T W de Jong-van den Berg
Journal:  Eur J Clin Pharmacol       Date:  2005-12-20       Impact factor: 2.953

2.  Sources of European drug consumption data at a country level.

Authors:  Pili Ferrer; Elena Ballarín; Mònica Sabaté; Joan-Ramon Laporte; Marieke Schoonen; Marietta Rottenkolber; Joan Fortuny; Joerg Hasford; Iain Tatt; Luisa Ibáñez
Journal:  Int J Public Health       Date:  2014-05-30       Impact factor: 3.380

3.  Prevalence and management of patients using medication targeting obstructive lung disease: a cross-sectional study in primary healthcare in Greenland.

Authors:  Sequssuna Olsen; Dorte Ejg Jarbøl; Mette Kofoed; Kim Abildskov; Michael Lynge Pedersen
Journal:  Int J Circumpolar Health       Date:  2013-02-28       Impact factor: 1.228

4.  Linking community pharmacy dispensing data to prescribing data of general practitioners.

Authors:  Stefan R Florentinus; Patrick C Souverein; Fabiënne A M G Griens; Peter P Groenewegen; Hubert G M Leufkens; Eibert R Heerdink
Journal:  BMC Med Inform Decis Mak       Date:  2006-04-03       Impact factor: 2.796

5.  Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years.

Authors:  Karolina A Andersson; Max G Petzold; Peter Allebeck; Anders Carlsten
Journal:  BMC Health Serv Res       Date:  2008-02-29       Impact factor: 2.655

6.  Influence of socioeconomic and demographic status on spirometry testing in patients initiating medication targeting obstructive lung disease: a population-based cohort study.

Authors:  Mette M Koefoed; Jens Søndergaard; René dePont Christensen; Dorte E Jarbøl
Journal:  BMC Public Health       Date:  2013-06-14       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.